Skip to main content
. Author manuscript; available in PMC: 2024 Dec 6.
Published in final edited form as: J Addict Med. 2022 Mar-Apr;16(2):169–176. doi: 10.1097/ADM.0000000000000851

TABLE 1.

Patient Characteristics and Index Admission Measures

Variable Total (n = 757) No MOUD (n = 516) Started MOUD (n = 241) Bivariate P Value
Age, median (IQR), years 47 (34–56) 50 (36–57.5) 40 (30–53) <0.001
Male sex 546 (72.13) 383 (74.22) 163 (67.63) 0.060
Race/ethnicity <0.001
White, non-Hispanic 356 (47.79) 215 (42.24) 141 (59.75)
Black, non-Hispanic 231 (31.01) 178 (34.97) 53 (22.46)
Hispanic 105 (14.09) 79 (15.52) 26 (11.02)
Other/unknown 53 (7.11) 37 (7.27) 16 (6.78)
English as primary language 713 (94.19) 476 (92.25) 237 (98.34) 0.001
Insurance type 0.086
Medicaid 566 (74.77) 375 (72.67) 191 (79.25)
Medicare 127 (16.78) 97 (18.80) 30 (12.45)
Other 64 (8.45) 44 (8.53) 20 (8.30)
Homelessness (n = 754) 377 (50.07) 233 (45.51) 144 (59.75) <0.001
Medication for OUD N/A
Methadone (median dose: 30 mg) 219 (90.87)
Buprenorphine (median dose: 10 mg) 22 (9.13)
Co-occurring disorders
Cocaine or other stimulant use 521 (68.82) 352 (68.22) 169 (70.12) 0.598
Alcohol use 237 (31.31) 180 (34.88) 57 (23.65) 0.002
Psychotic disorder 125 (16.51) 97 (18.80) 28 (11.62) 0.013
Anxiety disorder 233 (30.78) 164 (31.78) 69 (28.63) 0.381
Mood disorder 288 (38.04) 221 (42.83) 67 (27.80) <0.001
Severity of illness score, mean (SD) (n = 740) 2.33 (0.92) 2.35 (0.95) 2.26 (0.87) 0.238
Length of hospital stay, median (IQR), days 4 (3–7) 4 (2–6.5) 5 (3–8) 0.028

All values shown are n (%) for the column unless otherwise indicated.

IQR, interquartile range; MOUD, medication for opioid use disorder; OUD, opioid use disorder; SD, standard deviation.